ASCPT 2026 Annual Meeting is the premier gathering of clinical pharmacology and translational science professionals, taking place March 4th – 6th, 2026 in Denver, Colorado. The conference highlights cutting-edge scientific sessions, networking with leading researchers and industry experts, and a focus on Advancing Pharmacoequity to improve patient care, drug development, and global health through innovation and collaboration. 

In attendance will be members of our Simulations Plus team who will be happy to answer any questions. Come see us in the Partner Pavilion.

Can’t miss presentations!

Lunch and Learn: From Debate to Deployment: Responsible, Practical AI in MIDD
Date: Thursday, March 5th 
Time: 12:00 – 1:00 PM MST
Location: Summit 9

Artificial intelligence is no longer just a topic of debate in drug development—it is increasingly being implemented within Model-Informed Drug Development (MIDD) workflows. This panel moves beyond the promise of AI to focus on responsible, practical deployment: what is working today, what is evolving, and what it truly takes to integrate AI into real-world decision-making environments.

The discussion will consider the current regulatory landscape, including how emerging agency principles and expectations are influencing development strategies in practice. Panelists will share perspectives on where AI is being applied across MIDD today, where measurable value is already being realized, and how organizations are approaching strategic decisions around building, buying, or partnering to enable sustainable implementation.

Equally important, the session will address the human dimension of AI integration—highlighting where expert judgment remains central, how roles and workflows are adapting, and what skills will define successful MIDD scientists in an increasingly AI-enabled future.

Designed for scientists, industry leaders, and stakeholders across drug development, this conversation shifts from abstract potential to operational insight—exploring how responsible AI is moving from debate to deployment in MIDD.

Panelists:

• Rajanikanth Madabushi, Associate Director for Guidance and Scientific Policy, Office of Clinical Pharmacology, CDER/FDA
• Jeff Barrett, VP, Clinical Pharmacology & Quantitative Science at Genmab
• John Mondick, Head of Clinical and Quantitative Pharmacology at Incyte
• Mohamed Shahin, AI Strategy Lead, Pfizer
• Yue Zhao, Director, Pharmacometrics, Bristol Myers Squibb
• Amparo de la Peña, VP, Pharmacometric Services at Simulations Plus
• Susie Zhang, VP, Regulatory Strategies at Simulations Plus

Moderator:

• Viera Lukacova, Chief Scientific Officer at Simulations Plus

Lunch will be provided.  Space is limited, so come early to reserve your seat!

Title: Scaling the Summit of Membrane Protein Knowledge to Treat Rare Diseases 
Simulating Canalicular Transporter Impairment Using Quantitative Systems Toxicology Modeling Can Represent and Provide Insights into Rare Cholestatic Liver Diseases
Speaker: James J. Beaudoin, Ph.D. – Senior Scientist, Quantitative Systems Pharmacology
Date: Thursday, March 5th
Time: 1:40 PM – 2:00 PM MST (Full Session runs from 1:15 – 2:15 PM)
Location: Aurora Ballroom D

Title: One Size Never Fits All: The Promise and Pitfalls of Precision Medicine
Chair: Susie Zhang, Ph.D. – VP, Regulatory Strategies
Date: Thursday, March 5th, 2026
Time: 2:30 PM – 3:30 PM MST
Location: Aurora Ballroom D

Title: Getting It Right from the Start: MIDD-Driven Strategies for Including Individuals with Obesity in Clinical Trials
Using QSP Modeling Approaches to Predict Weight Loss and Nausea, Enabling the Optimization of Dosing Paradigms in Clinical Trials for Treatments in Patients with Obesity
Presenter: Scott Q. Siler, Ph.D. – Chief Science Officer, QSP
Date: Friday, March 6th, 2026
Time: 8:46 AM – 9:00 AM MST (Full Session runs from 8:15 – 9:15 AM MST)
Location: Crest 4

Simulations Plus Staff in Attendance: 

• Amparo de la Peña, Ph.D. – Vice President, Pharmacometric Services
• Yu-Nien (Tom) Sun, Ph.D. – Vice President, Strategic Consulting Services
• Viera Lukacova – Chief Scientific Officer
• Susie Zhang – VP, Regulatory Strategies
• Heather Squire B.S., CPM, HT – Director, Business Development, Services
• Saumi Rahatekar – Senior Director, Business Development
• James J. Beaudoin, Ph.D. – Senior Scientist, Quantitative Systems Pharmacology
• Kelly Maxwell Ph.D – Associate Director, Pharmacometrics
• David Jaworowicz – Distinguished Scientist, Pharmacometrics
• Scott Q. Siler, Ph.D. – Chief Science Officer, QSP